Literature DB >> 17126900

In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: mechanisms, key factors, and their implications.

Yong Woo Cho1, Soo Ah Park, Tae Hee Han, Dai Hyun Son, Ji Sun Park, Seung Jun Oh, Dae Hyuk Moon, Kyung-Ja Cho, Cheol-Hee Ahn, Youngro Byun, In-San Kim, Ick Chan Kwon, Sang Yoon Kim.   

Abstract

The development of more selective delivery systems for cancer diagnosis and chemotherapy is one of the most important goals of current anticancer research. The purpose of this study is to evaluate various self-assembled nanoparticles as candidates to shuttle radionuclide and/or drugs into tumors and to investigate the mechanisms underlying the tumor targeting with self-assembled nanoparticles. By combining different hydrophobic moieties and hydrophilic polymer backbones, various self-assembled nanoparticles were prepared, and their in vivo distributions in tumor-bearing mice were studied by radionuclide imaging. One type of nanoparticles (fluorescein isothiocyanate-conjugated glycol chitosan (FGC) nanoparticles) exhibited highly selective tumoral localization. Scintigraphic images obtained 1 day after the intravenous injection of FGC nanoparticles clearly delineated the tumor against adjacent tissues. The mechanisms underlying the tumor targeting with self-assembled nanoparticles were investigated in terms of the physicochemical properties of nanoparticles and tumor microenvironments. FGC nanoparticles were preferentially localized in perivascular regions, implying their extravasation to tumors through the hyperpermeable tumor vasculature. The magnitude and pattern of tumoral distribution of self-assembled nanoparticles were influenced by several key factors--(i) in vivo colloidal stability: nanoparticles should maintain their intact nanostructures in vivo for a long period of time, (ii) particle size, (iii) intracellular uptake of nanoparticle: fast cellular uptake greatly facilitates the tumor targeting, (iv) tumor angiogenesis: pathological angiogenesis permits access of nanoparticles to tumors. We believe that this work can provide insight for the engineering of nanoparticles and be extended to cancer therapy and diagnosis, so as to deliver multiple therapeutic agents and imaging probes at high local concentrations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17126900     DOI: 10.1016/j.biomaterials.2006.10.002

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  16 in total

1.  In vitro evaluation of polymeric micelles based on hydrophobically-modified sulfated chitosan as a carrier of doxorubicin.

Authors:  Xiu-Hua Wang; Qin Tian; Wei Wang; Chuang-Nian Zhang; Ping Wang; Zhi Yuan
Journal:  J Mater Sci Mater Med       Date:  2012-04-27       Impact factor: 3.896

Review 2.  Targeted delivery with peptidomimetic conjugated self-assembled nanoparticles.

Authors:  Esmaiel Jabbari
Journal:  Pharm Res       Date:  2008-12-17       Impact factor: 4.200

3.  A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer.

Authors:  Kai Xiao; Juntao Luo; Wiley L Fowler; Yuanpei Li; Joyce S Lee; Li Xing; R Holland Cheng; Li Wang; Kit S Lam
Journal:  Biomaterials       Date:  2009-08-05       Impact factor: 12.479

4.  Prostate cancer-targeted imaging using magnetofluorescent polymeric nanoparticles functionalized with bombesin.

Authors:  Chang-Moon Lee; Hwan-Jeong Jeong; Su-Jin Cheong; Eun-Mi Kim; Dong Wook Kim; Seok Tae Lim; Myung-Hee Sohn
Journal:  Pharm Res       Date:  2010-02-25       Impact factor: 4.200

Review 5.  Intratumoral drug delivery with nanoparticulate carriers.

Authors:  Hillary Holback; Yoon Yeo
Journal:  Pharm Res       Date:  2011-01-07       Impact factor: 4.200

6.  Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers.

Authors:  Ian R Corbin; Kenneth K Ng; Lili Ding; Andrea Jurisicova; Gang Zheng
Journal:  Nanomedicine (Lond)       Date:  2012-10-15       Impact factor: 5.307

7.  In vivo tumor cell targeting with "click" nanoparticles.

Authors:  Geoffrey von Maltzahn; Yin Ren; Ji-Ho Park; Dal-Hee Min; Venkata Ramana Kotamraju; Jayanthi Jayakumar; Valentina Fogal; Michael J Sailor; Erkki Ruoslahti; Sangeeta N Bhatia
Journal:  Bioconjug Chem       Date:  2008-07-09       Impact factor: 4.774

Review 8.  Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapy.

Authors:  Patrick Baril; Pilar Martin-Duque; Georges Vassaux
Journal:  Br J Pharmacol       Date:  2009-10-08       Impact factor: 8.739

9.  Elucidation of Molecular Mechanisms Behind the Self-Assembly Behavior of Chitosan Amphiphilic Derivatives Through Experiment and Molecular Modeling.

Authors:  Mohammad Mahmoudzadeh; Afshin Fassihi; Farid Dorkoosh; Reyhaneh Heshmatnejad; Karim Mahnam; Hassan Sabzyan; Amir Sadeghi
Journal:  Pharm Res       Date:  2015-08-12       Impact factor: 4.200

Review 10.  Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.

Authors:  Emily Gullotti; Yoon Yeo
Journal:  Mol Pharm       Date:  2009 Jul-Aug       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.